AMJ Neurology 1 [Supplement 1] . 2024

In this issue

Ozanimod is an approved treatment for relapsing forms of multiple sclerosis. This article summarizes the latest clinical trial data shared at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), and the 32nd Annual Meeting of the European Charcot Foundation.